BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6874287)

  • 1. Pharmacokinetic and haemodynamic studies with labetalol in acute myocardial infarction.
    Silke B; Nelson GI; Ahuja RC; Choudhury S; Taylor SH
    Ir J Med Sci; 1983 May; 152(5):179-86. PubMed ID: 6874287
    [No Abstract]   [Full Text] [Related]  

  • 2. alpha- and beta-blockade with labetalol in acute myocardial infarction.
    Nelson GI; Ahuja RC; Hussain M; Silke B; Taylor SH
    J Cardiovasc Pharmacol; 1982; 4(6):921-4. PubMed ID: 6185783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic effects of long-term oral labetalol.
    Edwards RC; Raftery EB
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemodynamic effects of labetalol in patients with acute myocardial infarct and systemic arterial hypertension].
    Cantelli I; Lombardi G; Naccarella F; Pavesi PC; Bracchetti D
    G Ital Cardiol; 1981; 11(1):110-8. PubMed ID: 7239092
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of hypertension in acute stage of myocardial infarction. Haemodynamic effects of labetalol.
    Renard M; Rivière A; Jacobs P; Bernard R
    Br Heart J; 1983 Jun; 49(6):522-7. PubMed ID: 6849714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic effects and plasma concentrations of labetalol during long-term treatment of essential hypertension.
    Lund-Johansen P; Bakke OM
    Br J Clin Pharmacol; 1979 Feb; 7(2):169-74. PubMed ID: 760749
    [No Abstract]   [Full Text] [Related]  

  • 7. [Influence of labetalol on the exercise tolerance test in patients with angina pectoris].
    Cherchi A; Fonzo R; Lai C; Mercuro G
    Boll Soc Ital Cardiol; 1978; 23(1):281-97. PubMed ID: 113022
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in rest and exercise hemodynamics during long term therapy with a combination alpha and beta blocker in essential hypertension].
    Koch G
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():219-20. PubMed ID: 349925
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular effects of labetalol during halothane anaesthesia.
    Scott DB; Buckley FP; Drummond GB; Littlewoods DG; Macrae WR
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):817-21. PubMed ID: 990159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of labetalol in acute myocardial infarction.
    Timmis AD; Fowler MB; Jaggarao NS; Vincent R; Chamberlain DA
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):111S-114S. PubMed ID: 7093093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
    Mehta J; Cohn JN
    Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulatory responses to thiopentone and tracheal intubation in patients with coronary artery disease. Effects of pretreatment with labetalol.
    Fischler M; Dubois C; Brodaty D; Schlumberger S; Melchior JC; Guilmet D; Vourc'h G
    Br J Anaesth; 1985 May; 57(5):493-6. PubMed ID: 3888239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of haemodynamic dose-response effects of beta- and alpha-beta-blockade in acute myocardial infarction.
    Silke B; Nelson GI; Ahuja RC; Walker C; Taylor SH
    Int J Cardiol; 1984 Mar; 5(3):317-25. PubMed ID: 6706437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
    Koch G
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the haemodynamic effects of labetalol in man.
    Cohn JN; Mehta J; Francis GS
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):19S-26S. PubMed ID: 7093099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combined alpha- and beta-adrenoreceptor blockade by labetalol.
    Koch G
    Br Heart J; 1979 Feb; 41(2):192-8. PubMed ID: 106867
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of labetalol on preload in acute myocardial infarction with systemic hypertension.
    Renard M; Jacobs P; Melot C; Haardt R; Vainsel H; Bernard R
    J Cardiovasc Pharmacol; 1984; 6(1):90-3. PubMed ID: 6199618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential haemodynamic effects of labetalol at rest and during exercise in essential hypertension.
    Svendsen TL; Rasmussen S; Hartling OJ; Nielsen PE; Trap-Jensen J
    Postgrad Med J; 1980; 56 Suppl 2():21-6. PubMed ID: 7433338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic advantages of combined alpha-blockade and beta-blockade over beta-blockade alone in patients with coronary heart disease.
    Taylor SH; Silke B; Nelson GI; Okoli RC; Ahuja RC
    Br Med J (Clin Res Ed); 1982 Jul; 285(6338):325-7. PubMed ID: 6807469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of hypertension: amelioration of left ventricular performance by treatment with labetalol.
    Belogi M; Ansuini R; Pupita G; Campolucci G; Pupita F
    Int J Clin Pharmacol Res; 1984; 4(5):385-7. PubMed ID: 6519853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.